Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (101-110 of 320) with videos related to

Pageof 32
Sort By:
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Differentiating EPA from EPA/DHA in cardiovascular risk reductionPeter P Toth, M John Chapman, Klaus G Parhofer, et al.
Journal of Lipid Research|May 6, 2003
Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37Wilfried Le Goff, Maryse Guerin, Laure Petit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 16, 2006
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteinsPatrick Maillard, Thierry Huby, Ursula Andréo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 11, 2004
Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levelsAndrei C Sposito, Sophie Gonbert, Gerard Turpin, et al.
BMJ Case Reports|June 13, 2012
Never trust a croupAndrew Nickinson, Jatinder Singh Minhas, Minak Bhalla, et al.
Current Medical Research and Opinion|August 25, 2004
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-CM John Chapman, Gerd Assmann, Jean-Charles Fruchart, et al.
Plos One|November 29, 2012
High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activitySandrine Chantepie, Andrea E Bochem, M John Chapman, et al.
Annals of Surgery|June 19, 2023
Surgical Episodes of Care for Price Transparency Using the Episode Grouper for MedicareJennifer Perloff, Rebecca Hasley, Senthil Subbiah Kumar, et al.
Journal of Clinical Lipidology|May 14, 2018
Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysisMartin Adiels, M John Chapman, Paul Robillard, et al.
Head and Neck Pathology|February 11, 2015
Composite Hemangioendothelioma of the Submandibular RegionSarah Lam Shang Leen, Peter M Clarke, John Chapman, et al.
Pageof 32

Showing results (101-110 of 320) with videos related to

Sort By:
Pageof 32
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Differentiating EPA from EPA/DHA in cardiovascular risk reductionPeter P Toth, M John Chapman, Klaus G Parhofer, et al.
Journal of Lipid Research|May 6, 2003
Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37Wilfried Le Goff, Maryse Guerin, Laure Petit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 16, 2006
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteinsPatrick Maillard, Thierry Huby, Ursula Andréo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 11, 2004
Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levelsAndrei C Sposito, Sophie Gonbert, Gerard Turpin, et al.
BMJ Case Reports|June 13, 2012
Never trust a croupAndrew Nickinson, Jatinder Singh Minhas, Minak Bhalla, et al.
Current Medical Research and Opinion|August 25, 2004
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-CM John Chapman, Gerd Assmann, Jean-Charles Fruchart, et al.
Plos One|November 29, 2012
High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activitySandrine Chantepie, Andrea E Bochem, M John Chapman, et al.
Annals of Surgery|June 19, 2023
Surgical Episodes of Care for Price Transparency Using the Episode Grouper for MedicareJennifer Perloff, Rebecca Hasley, Senthil Subbiah Kumar, et al.
Journal of Clinical Lipidology|May 14, 2018
Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysisMartin Adiels, M John Chapman, Paul Robillard, et al.
Head and Neck Pathology|February 11, 2015
Composite Hemangioendothelioma of the Submandibular RegionSarah Lam Shang Leen, Peter M Clarke, John Chapman, et al.
Pageof 32